Lehti Lab

@karolinskainst @MTC_KI and @NTNU
In Lehti group we study #TumorMicroenvironment #CancerInvasion #Metastasis #DrugResistance using 3D culture🔬🧫

[Jordi Gonzalez-Molina @jordigonzalezm2]

Happy to share our new study on the mechanical regulation of ovarian cancer invasion into adipose tissues! Here we develop adipose tissue-mimicking organo-hydrogels to investigate how cells invade these tissues, a central process in the establishment of metastases!

[Lehti Lab @LehtiLab]

@FrancesBalkwill @QMBCI @QMUL @CentreoftheCell So nice to hear. Congratulations Fran!

[Lehti Lab @LehtiLab]

@GlaumJulia @grande_tor I believe so too.

[Lehti Lab @LehtiLab]

Check out this this exiting study from @DhifafSarhan lab on the recently discovered adaptive NK cells, recruited to ovarian cancers by CXCR2!

[IARC @IARCWHO]

Over 35 million new cases are predicted in 2050, a 77% increase vs cases in 2022. Tobacco🚬, alcohol🍺🍷 & obesity🍔 are key lifestyle risk factors behind the increasing incidence.
Air pollution remains a major environmental risk factor🌬️.
https://t.co/jQyiCQdZH1

[Lehti Lab @LehtiLab]

@NathalieJuYa @NTNU Important discussion around how to maintain national uniqueness in countries like those in the Northern Europe, while simultaneously supporting international cooperation and global developments 💡

[Nathalie Jurisch-Yaksi @NathalieJuYa]

The Norwegian government wants to implement a new rule requiring all temporary employees (PhD students and postdocs) to obtain 15 credits in Norwegian language within their 3 years contract. This piece written by Karina Rose Mahan @NTNU is very relevant! https://t.co/yWdqEgL1cd

[Karolinska Institutet @karolinskainst]

.@seashoreludlow and colleagues at KI and @scilifelab present a #PrecisionMedicine platform with 3D cell cultures that can identify effective drugs and drug combinations for #OvarianCancer patients. The study is published in @Nature_NPJ Precision #Oncology https://t.co/qVZb9VYVzJ

[Organoid News @organoidscience]

Dr. @asmundflobak's team at @NTNUnorway presents a systematic 📖 #review of studies that tested the performance of patient-derived #organoids to predict the effect of anti-cancer therapies in #ColorectalCancer, for chemotherapies, and more!

@SciReports | https://t.co/Ql6UyMyEcv

[Lehti Lab @LehtiLab]

”The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients”

Congratulations and thank you for the opportunity to participate Brinton Seashore-Ludlow, Emma Åkerlund and all co-authors!

https://t.co/VciQDovKwx

[Åsmund Flobak @asmundflobak]

We recruit one PHD candidate for cell lab work on functional precision medicine. Colon cancer cells direclty from patients are exposed to drugs to find the best therapy for each patient. Deadline Nov 22nd: https://t.co/9ct2tZGagV

@NTNU @SINTEF @StOlavshospital @fkbmatrix

[Johan Kippervik @doktorjohan]

@asmundflobak @NTNU @SINTEF @StOlavshospital @fkbmatrix Du har ikke noen ovarialcancerceller vi kan gjøre det samme med da? 😁

[Tor Grande @grande_tor]

Fantastic news! Congratulations to NTNU professors James R. Dawson and Thorsten Hamann. The two ERC SYNERGY grants represent two important research topics, which will be exciting to follow in future.

[Cell @CellCellPress]

Today Cell, Cancer Cell and Cell Reports Medicine are pleased to publish the 1st wave of Pan-#Cancer multiomics papers looking at over 1000 patients across 10 #tumor types from @theNCI Clinical Proteomic Tumor Analysis Consortium #CPTAC (1/n) @Cancer_Cell @CellRepMed #openaccess

[Jordi Gonzalez-Molina @jordigonzalezm2]

This work resulted from Lara Closset’s efforts during the pandemic that continued until now and great contributions from @okangultekinphd @LehtiLab @DhifafSarhan @Dr_S_Salehi

[2nd Virtual BMP Forum @bmp_forum]

Excited to announce our next session: "BMP signaling and vascular biology" chaired by Paul Yu Aug. 23. Mohamed Al-Shabrawey and Lei Wang are presenting their interesting work. Please share! Register here: https://t.co/bUAaN3qHbP

[Jordi Gonzalez-Molina @jordigonzalezm2]

Our new review is out (my first last author)! Here we discuss how cancer therapies reshape the #ECM - #immune microenvironment crosstalk and how can we exploit it to improve therapy response. https://t.co/xRe3hO4eqZ

[Lehti Lab @LehtiLab]

Huge congratulations Viviam and Marco✨🏅
Wonderful to do research with the young talents. Looking forward to hear more what you learned and experienced in this exciting meeting!
@asmundflobak @mtrkuiper @eirini_tsi

[Åsmund Flobak @asmundflobak]

CONGRATULATIONS to Viviam Bermúdez and Marco Fariñas both @NTNU, and to @malvina_marku for well deserved prizes for best posters @PerMedCoE summer school! @mtrkuiper @eirini_tsi @LehtiLab

[Terje Johansen @TerjeJohansen17]

Fantastic new tools to spy on protein movements inside and between cells from@aliceyting😀👏👍